[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Solventum Corporation (SOLV)

Solventum Corporation (SOLV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Are Wall Street Analysts Bullish on Solventum Stock?

Solventum Corporation (SOLV), with a market capitalization of approximately $14.5 billion, is a global healthcare company that develops solutions using health, material, and data science. The Eagan, Minnesota-based company’s technologies help healthcare professionals improve patient outcomes, enhance efficiency, and deliver better, smarter, safer care.

Shares of this leading healthcare company have slightly underperformed the broader market over the past year. SOLV has gained 16.2% over this period, while the broader S&P 500 Index ($SPX) has rallied 20.6%. On a year-to-date basis, SOLV has also underperformed, gaining 9.1% compared with the index’s 13.9% gain over the same period.

Fundamentals

See More
  • Market Capitalization, $K 15,080,142
  • Shares Outstanding, K 170,224
  • Annual Sales, $ 8,325 M
  • Annual Income, $ 1,556 M
  • EBIT $ 2,076 M
  • EBITDA $ 2,565 M
  • 60-Month Beta 0.60
  • Price/Sales 1.77
  • Price/Cash Flow 9.62
  • Price/Book 3.12

Options Overview Details

View History
  • Implied Volatility 27.97% (-1.08%)
  • Historical Volatility 37.54%
  • IV Percentile 27%
  • IV Rank 31.44%
  • IV High 43.75% on 02/12/26
  • IV Low 20.73% on 12/26/25
  • Expected Move (DTE 6) 2.31 (2.61%)
  • Put/Call Vol Ratio 0.06
  • Today's Volume 563
  • Volume Avg (30-Day) 1,303
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 22,677
  • Open Int (30-Day) 14,014
  • Expected Range 86.28 to 90.90

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $1.40
  • Number of Estimates 5
  • High Estimate $1.53
  • Low Estimate $1.36
  • Prior Year $1.50
  • Growth Rate Est. (year over year) -6.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.69 +17.04%
on 07/15/26
90.00 -1.57%
on 08/06/26
+12.31 (+16.14%)
since 07/14/26
3-Month
72.74 +21.79%
on 05/20/26
90.00 -1.57%
on 08/06/26
+14.17 (+19.04%)
since 05/14/26
52-Week
62.38 +42.02%
on 04/07/26
90.00 -1.57%
on 08/06/26
+15.39 (+21.02%)
since 08/14/25

Most Recent Stories

More News
Are Wall Street Analysts Bullish on Solventum Stock?

Solventum has underperformed the broader market, while analysts remain moderately optimistic about its future prospects.

SOLV : 88.59 (+2.46%)
$SPX : 7,785.76 (-0.17%)
FXH : 131.22 (-0.21%)
SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook

SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook

SOLV : 88.59 (+2.46%)
Solventum Nears Inflection Point As It Begins to Unlock Value

Solventum shares gain on strong Q2 revenue, earnings, and cash flow, buybacks, and improved guidance, with analysts raising price targets amid a discounted valuation versus med/tech peers.

SOLV : 88.59 (+2.46%)
ABT : 111.25 (-0.02%)
JNJ : 260.35 (-0.66%)
Solventum (NYSE:SOLV) Posts Better-Than-Expected Sales In Q2 CY2026

Solventum (NYSE:SOLV) Posts Better-Than-Expected Sales In Q2 CY2026

SOLV : 88.59 (+2.46%)
Solventum: Q2 Earnings Snapshot

Solventum: Q2 Earnings Snapshot

SOLV : 88.59 (+2.46%)
Solventum Reports Second Quarter 2026 Financial Results

EAGAN, Minn. , Aug. 5, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the second quarter ended June 30, 2026.

SOLV : 88.59 (+2.46%)
Solventum Announces Intent to Separate its Health Information Systems Business

EAGAN, Minn. , Aug. 5, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) today announced its intention to pursue a separation of its Health Information Systems business as part of the company's ongoing...

SOLV : 88.59 (+2.46%)
Solventum's Transformation Thesis Gets Its First Real Test Tomorrow

Barchart Research What to Expect from SOLV Earnings SOLV Generated August 4, 2026 Current Price $87.94 EPS Estimate $$1.91 Consensus Rating Moderate Buy Average Move 4.12% Solventum's Transformation Thesis...

SOLV : 88.59 (+2.46%)
What To Expect From Solventum’s (SOLV) Q2 Earnings

What To Expect From Solventum’s (SOLV) Q2 Earnings

SOLV : 88.59 (+2.46%)
3 Hyped Up Stocks That Fall Short

3 Hyped Up Stocks That Fall Short

SOLV : 88.59 (+2.46%)
HOPE : 14.45 (-0.34%)
ADUS : 116.06 (-1.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.

See More

Key Turning Points

3rd Resistance Point 94.47
2nd Resistance Point 91.98
1st Resistance Point 90.28
Last Price 88.59
1st Support Level 86.09
2nd Support Level 83.60
3rd Support Level 81.90

See More

52-Week High 90.00
Last Price 88.59
Fibonacci 61.8% 79.45
Fibonacci 50% 76.19
Fibonacci 38.2% 72.93
52-Week Low 62.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.